Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Olga, Michail"'
1
Effect of Bruton's tyrosine kinase inhibitors on platelet aggregation in patients with acute myocardial infarction
Autor: Maria Bhatti, Tobias Geisler, Nicholas D. Gollop, Stuart A. Rushworth, Kristian M. Bowles, Alisdair Ryding, Marcus Flather, Olga Michail, Sarah Ayton
Publikováno v: Thrombosis Research. 179:64-68
Aims: Despite widespread use of dual antiplatelet therapy in acute myocardial infarction, there remains a residual risk of morbidity and mortality. Bruton's Tyrosine Kinase inhibitors have been found to inhibit platelet aggregation through the Glycop
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c7595e86410695b76531dded8318fe
https://doi.org/10.1016/j.thromres.2019.04.024
Zobrazit plný text záznamu
2
Mutational profiling in suspected triple-negative essential thrombocythaemia using targeted next-generation sequencing in a real-world cohort
Autor: Mary Frances McMullin, Patrick McCallion, Roisin McAllister, Robert J. G. Cuthbert, Julie McGimpsey, Andrew Hindley, Olga Michail, Nicholas C.P. Cross, Graeme Greenfield, John Feerick, Claire Arnold, Mark Catherwood
Publikováno v: Michail, O, McCallion, P, McGimpsey, J, Hindley, A, Greenfield, G, Feerick, J, Arnold, C, Cross, N, Cuthbert, R, McMullin, M F & Catherwood, M A 2020, ' Mutational profiling in suspected triple-negative essential thrombocythaemia using targeted next-generation sequencing in a real-world cohort ', Journal of Clinical Pathology . https://doi.org/10.1136/jclinpath-2020-206570
Essential thrombocythaemia (ET) is driven by somatic mutations involving the JAK2, CALR and MPL genes. Approximately 10% of patients lack driver mutations and are referred as ‘triple-negative’ ET (TN-ET). The diagnosis of TN-ET, however, relies o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366eccd761cc2ee2f1507e66fd2cce27
https://pure.qub.ac.uk/en/publications/mutational-profiling-in-suspected-triplenegative-essential-thrombocythaemia-using-targeted-nextgeneration-sequencing-in-a-realworld-cohort(19570fa7-5833-4742-ade0-a2c0e529570f).html
Zobrazit plný text záznamu
6
7 Serial measurement of NT-PROBNP AND HS-CRP after acute coronary syndromes could identify patients with higher residual risk
Autor: Marcus Flather, Ian Nunney, Christopher Washbourne, Olga Michail, Alisdair Ryding, Jonathan Tang, Nicholas D. Gollop, Maria Bhatti, Sarah Ayton
Publikováno v: Acute Coronary Syndromes.
Background Serial measurement of NT-proBNP and high sensitivity C-reactive protein (hs-CRP) after an acute coronary syndrome (ACS) may help to identify patients at continuing risk of future events, although this is not currently recommended in guidel
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9ec5a0c83f52b4dd452488f674c03f44
https://doi.org/10.1136/heartjnl-2018-bcs.7
Zobrazit plný text záznamu
7
8 The effect of BTK inhibitors on platelet aggregation in acute coronary syndromes
Autor: Kristian M. Bowles, Nicholas D. Gollop, Maria Bhatti, Stuart A. Rushworth, Sarah Ayton, Olga Michail, Alisdair Ryding, Marcus Flather
Publikováno v: Acute Coronary Syndromes.
Introduction Dual antiplatelet therapy is a cornerstone of long term management of Acute Coronary Syndrome (ACS), but despite this there is a residual risk of morbidity and mortality. Bruton’s Tyrosine Kinase (BTK) inhibitors are currently indicate
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4156bd1d073120231eeddcc3027a515d
https://doi.org/10.1136/heartjnl-2018-bcs.8
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje